PI: Rory Johnson

Our mission is to develop new treatments for common diseases based on RNA therapeutics. In particular, we develop oligonucleotide drugs targeting cancer-causing long non-coding RNAs (lncRNAs), which we discover using CRISPR-Cas genome-editing and bioinformatics.

We are an interdisciplinary research group based at University College Dublin, and funded by Science Foundation Ireland through the 'Future Research Leaders' programme.

For more information go to Projects


Gold Lab in the media

2018                                                     article here

2017                                                     article here


 Latest News

We use genome-editing and bioinformatics to create (non-coding) RNA therapeutics.